On July 7, 2023, Ingalls & Snyder, LLC announced that along with other shareholders are collectively proposing a change to the members of ImmunoPrecise Antibodies Ltd.’s board of directors. Ingalls & Snyder stated that the views of the informal group would be expressed through written and oral communications and might result in a call for a shareholder meeting on the issue.